Skip to main content

2023 IKCS: Europe Main banner

Tweets by 2023 IKCS: Europe

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

C
9
Characterisation of HIF-mediated genoprotection in clear cell renal cell carcinoma
Basic Science

Favorite
7
Circulating B cells subpopulations and outcomes to Checkpoint Blockade in patients with renal cell carcinoma.
Basic Science

Favorite
32
Clinical benefit of cabozantinib in patients with advanced renal cell carcinoma (aRCC) after checkpoint inhibitor (CPI) therapy: interim results from the Phase 2 CaboPoint trial
Therapeutics- Local (Primary and Metastases)

Favorite
16
Clinical Outcome of Patients with Primary Metastatic Renal Cell Carcinoma Carefully Selected for Cytoreductive Nephrectomy: A Nationwide Real-World Data
Real-World Evidence

Favorite
11
Correlation of PSMA expression on [18F]PSMA-1007 PET with morphological changes in patients with metastatic renal cell cancer undergoing tyrosine kinase and checkpoint inhibitor therapy
Imaging

Favorite